KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to 0.41.

  • Johnson & Johnson's Equity Ratio rose 312.38% to 0.41 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.41, marking a year-over-year increase of 312.38%. This contributed to the annual value of 0.41 for FY2025, which is 312.38% up from last year.
  • According to the latest figures from Q4 2025, Johnson & Johnson's Equity Ratio is 0.41, which was up 312.38% from 0.41 recorded in Q3 2025.
  • Johnson & Johnson's 5-year Equity Ratio high stood at 0.43 for Q3 2022, and its period low was 0.36 during Q2 2023.
  • Its 5-year average for Equity Ratio is 0.4, with a median of 0.41 in 2025.
  • As far as peak fluctuations go, Johnson & Johnson's Equity Ratio plummeted by 1366.61% in 2023, and later soared by 1259.28% in 2024.
  • Over the past 5 years, Johnson & Johnson's Equity Ratio (Quarter) stood at 0.39 in 2021, then grew by 8.65% to 0.43 in 2022, then fell by 3.65% to 0.41 in 2023, then dropped by 3.29% to 0.4 in 2024, then increased by 3.12% to 0.41 in 2025.
  • Its last three reported values are 0.41 in Q4 2025, 0.41 for Q3 2025, and 0.41 during Q2 2025.